Picture loading failed.

Anti-AXL therapeutic antibody (Pre-made Mipasetamab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Mipasetamab Uzoptirine or ADCT-601 ia humanized antibody that binds to human AXL conjugated using Glycoconnect? technology to a linker with a PBD-dimer toxin. Once bound to an AXL-expressing cell, ADCT-601 is internalized into the cell, where enzymes release the PBD-based payload.

Order information

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-345-1mg 1mg 3090
GMP-Bios-ab-345-10mg 10mg 21890
GMP-Bios-ab-345-100mg 100mg 148000
GMP-Bios-ab-345-xmg >100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-AXL therapeutic antibody (Pre-made Mipasetamab biosimilar,Whole mAb)
INN Name Mipasetamab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2020
Year Recommended2021
CompaniesADC Therapeutics
Conditions Approvedna
Conditions ActiveSolid tumours;Advanced or metastatic solid tumours
Conditions Discontinuedna
Development Techna